Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medibio Ltd (MEB.AX)

Medibio Ltd (MEB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medibio Ltd 100 Albert Road Level 4 Melbourne VIC 3205 AUS

P: +61 396927222

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.

Key Statistics

Overview:

Market Capitalization, $K 6,101
Shares Outstanding, K 6,100,744
% of Institutional Shareholders 7.05%

Financials:

Annual Sales, $ 40 K
Annual Net Income, $ -12,716 K

Growth:

1-Year Return 0.00%
3-Year Return -90.91%
5-Year Return -98.08%
5-Year Revenue Growth 11.63%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.00
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/24/23

MEB.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -102.08%
Return-on-Assets % -94.46%
Profit Margin % -31,759.35%
Debt/Equity N/A
Price/Sales 161.34
Price/Book 0.97
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar